Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Multiple dosing of AMG-853 well tolerated in healthy volunteers

Sep. 23, 2010

High loading dose of clopidogrel may overcome effects of CYP2C19 genetic variant in persons with CAD

Sep. 23, 2010

Fixed-dose fenofibrate/pravastatin plus ezetimibe reduces hyperlipidemia in type 2 diabetes

Sep. 23, 2010

First selective Aurora kinase A inhibitors identified

Sep. 23, 2010

Peretinoin shows potential as first-line agent to prevent recurrence of HCC

Sep. 22, 2010

Phase III data presented on bisoprolol vs. carvedilol in elderly subjects with CHF

Sep. 22, 2010

Galapagos develops new phosphodiesterase 1A inhibitors for osteoarthritis

Sep. 22, 2010

Palau Pharma identifies new histamine H4 receptor antagonists

Sep. 22, 2010

Preliminary phase I data on fully human anti-PNAG mAb F-598 disclosed

Sep. 22, 2010

SCH-527123 is safe and efficacious in phase II trial in COPD

Sep. 21, 2010

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...